Literature DB >> 21454405

Hyperglycemia and the fate of apparent diffusion coefficient-defined ischemic penumbra.

C Rosso1, Y Attal, S Deltour, N Hevia-Montiel, S Lehéricy, S Crozier, D Dormont, S Baillet, Y Samson.   

Abstract

BACKGROUND AND
PURPOSE: Previous data have shown the feasibility of identifying ischemic penumbra in patients with acute stroke by using a semiautomated analysis of ADC maps. Here, we investigated whether the fate of ADC-defined penumbra was altered by HG. We also examined the interaction between HG and arterial recanalization on infarct growth.
MATERIALS AND METHODS: We examined 94 patients by using MR imaging within 6 hours of stroke onset and a follow-up MR imaging within 7 days. The ADC-defined tissue-at-risk was calculated from the early MR imaging. Patients were classified according to high (>7 mmol/L; n = 34/94, HG) or normal (n = 60/94) baseline SGL. The impact of HG status on infarct growth was assessed by using multiple regression models and analysis of the slopes of regression lines for each group. Interaction between HG status and arterial recanalization on infarct growth was investigated by using multiple regression analysis.
RESULTS: The slope of the predicted versus observed infarct growth regression line was steeper in HG than non-HG patients (P = .0008), suggesting that infarct growth within ADC-defined tissue-at-risk was increased in HG patients. The effect was 2.8 times more severe in nonrecanalized patients (P = .01) than in patients with recanalization (P = .001).
CONCLUSIONS: ADC-defined tissue-at-risk may represent ischemic penumbra because part of this area may be salvaged in normal SGL patients. The toxicity in HG patients seems to be more related to penumbra-infarction transition than reperfusion injury in humans because the effect was larger in nonrecanalized than in recanalized patients.

Entities:  

Mesh:

Year:  2011        PMID: 21454405      PMCID: PMC7965540          DOI: 10.3174/ajnr.A2407

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  34 in total

Review 1.  Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.

Authors:  S E Capes; D Hunt; K Malmberg; P Pathak; H C Gerstein
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

2.  Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data.

Authors:  Thanh G Phan; Geoffrey A Donnan; Stephen M Davis; Graham Byrnes
Journal:  Stroke       Date:  2006-08-24       Impact factor: 7.914

3.  Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke.

Authors:  T Neumann-Haefelin; H J Wittsack; F Wenserski; M Siebler; R J Seitz; U Mödder; H J Freund
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

4.  Blood pressure response to glucose potassium insulin therapy in patients with acute stroke with mild to moderate hyperglycaemia.

Authors:  J F Scott; G M Robinson; J M French; J E O'Connell; K G Alberti; C S Gray
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

5.  Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.

Authors:  Marc Ribo; Carlos A Molina; Pilar Delgado; Marta Rubiera; Raquel Delgado-Mederos; Alex Rovira; Josep Munuera; Jose Alvarez-Sabin
Journal:  J Cereb Blood Flow Metab       Date:  2007-02-14       Impact factor: 6.200

Review 6.  [Insulin in the treatment of ischemic stroke].

Authors:  Yves Samson; Marie Bruandet; Marie Lejeune; Sandrine Deltour; André Grimaldi
Journal:  Presse Med       Date:  2006-04       Impact factor: 1.228

7.  Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.

Authors:  T Neumann-Haefelin; R du Mesnil de Rochemont; J B Fiebach; A Gass; C Nolte; T Kucinski; J Rother; M Siebler; O C Singer; K Szabo; A Villringer; P D Schellinger
Journal:  Stroke       Date:  2003-12-11       Impact factor: 7.914

8.  Automatic prediction of infarct growth in acute ischemic stroke from MR apparent diffusion coefficient maps.

Authors:  Nidiyare Hevia Montiel; Charlotte Rosso; Narie Chupin; Sanorine Deltour; Eric Bardinet; Didier Dormont; Yves Samson; Sylvain Baillet
Journal:  Acad Radiol       Date:  2008-01       Impact factor: 3.173

9.  Insulin reduction of cerebral infarction due to transient focal ischemia.

Authors:  M G Hamilton; B I Tranmer; R N Auer
Journal:  J Neurosurg       Date:  1995-02       Impact factor: 5.115

10.  Prediction of infarct growth based on apparent diffusion coefficients: penumbral assessment without intravenous contrast material.

Authors:  Charlotte Rosso; Nidiyare Hevia-Montiel; Sandrine Deltour; Eric Bardinet; Didier Dormont; Sophie Crozier; Sylvain Baillet; Yves Samson
Journal:  Radiology       Date:  2008-11-18       Impact factor: 11.105

View more
  7 in total

Review 1.  Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism.

Authors:  Nathaniel M Robbins; Raymond A Swanson
Journal:  Stroke       Date:  2014-04-17       Impact factor: 7.914

2.  Effect of In-Hospital Remote Ischemic Perconditioning on Brain Infarction Growth and Clinical Outcomes in Patients With Acute Ischemic Stroke: The RESCUE BRAIN Randomized Clinical Trial.

Authors:  Fernando Pico; Bertrand Lapergue; Marc Ferrigno; Charlotte Rosso; Elena Meseguer; Marie-Laure Chadenat; Frederic Bourdain; Michael Obadia; Catherine Hirel; Duc Long Duong; Sandrine Deltour; Philippe Aegerter; Julien Labreuche; Amina Cattenoy; Didier Smadja; Hassan Hosseini; Benoit Guillon; Valérie Wolff; Yves Samson; Charlotte Cordonnier; Pierre Amarenco
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

3.  Immune-Inflammatory, Metabolic, Oxidative, and Nitrosative Stress Biomarkers Predict Acute Ischemic Stroke and Short-Term Outcome.

Authors:  Daniela Frizon Alfieri; Marcio Francisco Lehmann; Tamires Flauzino; Maria Caroline Martins de Araújo; Nicolas Pivoto; Rafaele Maria Tirolla; Andrea Name Colado Simão; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Neurotox Res       Date:  2020-05-15       Impact factor: 3.911

4.  Hyperglycemia accelerates apparent diffusion coefficient-defined lesion growth after focal cerebral ischemia in rats with and without features of metabolic syndrome.

Authors:  David Tarr; Delyth Graham; Lisa A Roy; William M Holmes; Christopher McCabe; I Mhairi Macrae; Keith W Muir; Deborah Dewar
Journal:  J Cereb Blood Flow Metab       Date:  2013-07-10       Impact factor: 6.200

5.  Hyperglycaemia, insulin therapy and critical penumbral regions for prognosis in acute stroke: further insights from the INSULINFARCT trial.

Authors:  Charlotte Rosso; Christine Pires; Jean-Christophe Corvol; Flore Baronnet; Sophie Crozier; Anne Leger; Sandrine Deltour; Romain Valabregue; Mélika Amor-Sahli; Stéphane Lehéricy; Didier Dormont; Yves Samson
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  Hyperglycaemia does not increase perfusion deficits after focal cerebral ischaemia in male Wistar rats.

Authors:  Lisa A Thow; Kathleen MacDonald; William M Holmes; Keith W Muir; I Mhairi Macrae; Deborah Dewar
Journal:  Brain Neurosci Adv       Date:  2018-08-20

7.  The silver effect of admission glucose level on excellent outcome in thrombolysed stroke patients.

Authors:  Charlotte Rosso; Flore Baronnet; Belen Diaz; Raphael Le Bouc; Giulia Frasca Polara; Eric Jr Moulton; Sandrine Deltour; Anne Leger; Sophie Crozier; Yves Samson
Journal:  J Neurol       Date:  2018-05-18       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.